Genetic regulatory circuit monitors blood fat
The research group headed by ETH-Zurich professor Martin 
Fussenegger from the Department of Biosystems Science and Engineering in
 Basel has now developed an early warning system and treatment: an 
implantable genetic circuit mainly composed of human gene components. On
 the one hand, it constantly monitors the circulating fat levels in the 
blood. On the other hand, it has a feedback function and forms a 
messenger substance in response to excessively high blood-fat levels 
that conveys a sense of satiety to the body.
In order to construct this highly complex regulatory 
circuit, the biotechnologists skilfully combined different genes that 
produce particular proteins and reaction steps. They implanted the 
construct in human cells, which they then inserted into tiny capsules.
The researchers studied obese mice that had been fed fatty 
food. After the capsules with the gene regulatory circuit had been 
implanted in the animals and intervened due to the excessive levels, the
 obese mice stopped eating and their bodyweight dropped noticeably as a 
result. As the blood-fat levels also returned to normal, the regulatory 
circuit stopped producing the satiety signal.
“Instead of placing the mice on a diet to achieve weight 
loss, we kept giving the animals as much high-calorie food as they could
 eat,” stresses Fussenegger. The animals ate less because the implant 
signalised a feeling of satiety to them. Mice that received normal 
animal feed with a five-per-cent fat content did not lose any weight or 
reduce their intake of food, says the biotechnologist.
Sensor for different dietary fats
One major advantage of the new synthetic regulatory circuit
 is the fact that it is not only able to measure one sort of fat, but 
rather several saturated and unsaturated animal and vegetable fats that 
are ingested with food at once. However, this development cannot simply 
be transferred to humans. It will take many years to develop a suitable 
product. Nonetheless, Fussenegger can certainly envisage that one day 
obese people with a body mass index of way over thirty could have such a
 gene network implanted to help them lose weight. Fussenegger sees the 
development as a possible alternative to surgical interventions such as 
liposuction or gastric bands. “The advantage of our implant would be 
that it can be used without such invasive interventions.” Another merit:
 instead of intervening in the progression of a disease that is 
difficult to regulate, it has a preventive effect and exploits the 
natural human satiety mechanism.
This gene network is one of the most complex that 
Fussenegger and his team have constructed to date and was made possible 
thanks to the biotechnologist’s years of experience in the field. It is 
not the first time he and his team have succeeded in constructing such a
 complex feedback regulatory circuit: a number of years ago, they 
produced an implant that can also be used to combat gout via a feedback 
regulatory circuit.






